Epilepsy and neurocardiogenic syncope share a final common pathway of loss of consciousness and consequent social disruption. We compared 52 patients with syncope, 96 with epilepsy and 100 controls. Epilepsy and syncope patients expressed significantly higher levels of anxiety and depression and reported significantly less good quality of life (QoL) compared with controls. There were no significant differences on any of the QoL parameters measured between the syncope and epilepsy patients. These findings suggest the main contributor to poor QoL in epilepsy may be the unpredictable loss of control that is the hallmark of the condition.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1528-1167.2006.00971.xDOI Listing

Publication Analysis

Top Keywords

syncope epilepsy
12
quality life
8
epilepsy neurocardiogenic
8
neurocardiogenic syncope
8
epilepsy
6
syncope
5
comparison self-reported
4
self-reported quality
4
patients
4
life patients
4

Similar Publications

Epileptic seizures, which are often accompanied by a reduction in vigilance, are a common emergency. Every first-time epileptic seizure should be investigated further. Particular attention should be paid to whether it is an acute symptomatic seizure, which is an acute event characterized by a metabolic disorder or acute cerebral damage within a certain period of time, or possibly epilepsy.

View Article and Find Full Text PDF

Background: Syncope is a common medical condition. The reflex or neurally mediated syncope (NMS) is the most frequent type. The tilt table test (TTT) helps distinguish syncope from other common causes of complete loss of consciousness, such as epilepsy, define syncope subtypes and guide management.

View Article and Find Full Text PDF

Amyloid light chain (AL) amyloidosis is a disease in which ALs, which are proteins with fibrous structures, are deposited in systemic organs, causing functional impairment. Diagnosis is often difficult because of non-specific and varied symptoms. We report a case of systemic AL amyloidosis that was diagnosed as a result of repeated syncope.

View Article and Find Full Text PDF

Drug-Induced Type 1 Brugada Pattern: A Case Report.

Cureus

November 2024

Internal Medicine, University Hospitals Sussex NHS Foundation Trust, St Richard's Hospital, Chichester, GBR.

Article Synopsis
  • Brugada syndrome is a genetic heart disorder characterized by abnormal heart rhythms, leading to fainting and potential sudden death, even in otherwise healthy individuals.
  • A 33-year-old man was diagnosed with drug-induced type 1 Brugada pattern after experiencing syncopal episodes that mimicked seizures, with no history of heart issues or epilepsy.
  • The antidepressant dosulepin was identified as the likely trigger for the condition, and a psychiatry consult was recommended to evaluate medication alternatives.
View Article and Find Full Text PDF

Epilepsy and Cardiac Arrhythmias: A State-of-the-Art Review.

JACC Clin Electrophysiol

November 2024

Department of Cardiology, St Vincent's Hospital Melbourne, Fitzroy, VIC, Australia; Faculty of Medicine, Dentistry & Health Sciences, The University of Melbourne, Fitzroy, VIC, Australia; HEART Lab, St Vincent's Institute of Medical Research, Fitzroy, VIC, Australia; HEART Lab, Victor Chang Cardiac Research Institute, Darlinghurst, NSW, Australia. Electronic address: https://twitter.com/pretzeldr.

Epilepsy is an important cause of disability and mortality worldwide. It can be frequently misdiagnosed, and detailed history and relevant investigations are needed to differentiate epilepsy from syncope. Electroencephalogram is a key noninvasive assessment of neurological function, and the diagnostic yield is increased when performed for an extended period in the ambulatory setting with concurrent electrocardiogram and video monitoring.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!